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Breath holding spells are one of the most frequent and important
diagnostic challenges in pediatrics. The aim of this study, conducted
on pediatric patients referring to the pediatric neurology clinic in
Hormozgan province, was to evaluate therapeutic effects of iron on
breath holding spells
Materials and Methods:
35 children (19 males and 16 females), aged between 3 to 60 months,
with a history of breath-holding spells, were included in the trial. To
obtain all relevant data a specifically designed questionnaire requiring
information on sex, age, age of onset of spells, type of spells, frequency
of attacks before and after treatment with oral iron supplement, and
determinants of body iron stores was completed for all the patients,
based on the mother’s statements. The patients were treated by an
oral iron preparation for three months.
Results:
The age of onset of spells ranged between 6 to 24 months. The
cyanotic type of spell was detected in 31 children, the pallid type in
3, and the mixed type in one child. There were 14 children with iron
deficiency anemia and 20 children with reduced iron stores. Just one
child had a normal iron profile. Complete therapeutic response was
documented in 24 children, good response in 9, and poor response
in one and in one child no change in frequency of spells was seen.
Conclusion:
Although no significant therapeutic difference was seen in the different
response groups, it seems that iron supplement may play an important
role in reducing breath holding spells in children.
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Breath holding spells (BHS) are dramatic, involuntary episodes that occur in
otherwise healthy children; the attacks, self-limited, are usually outgrown by
school age (1). The spells are rare before the age of 6 months, peak around 2 years
of age and abate by 5 year of age (2). There are two major types of BHS, the
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cyanotic and the pallid type. Cyanotic BHS, the most
common form is provoked by upsetting or scolding an
infant, continues with a forced expiration, and is followed
by apnea. There is rapid onset of generalized cyanosis
and loss of consciousness that may be associated with
clonic jerks and opisthotonus (2). Many studies have
investigated different treatments for breath holding spells
in children, with no definite therapy being documented
and research continues. Earlier studies show the presence
of concomitant iron deficiency in this group of patients;
breath-holding episodes occur in up to 27% of children
with iron-deficiency (3). Anemia, because of more rapid
cerebral anoxia, exacerbates the likelihood of breath-
holding episodes (3, 4). There are reports of an association
between iron deficiency anemia and breath-holding
episodes with a decrease or cessation of the episodes
after iron therapy (5). This study was undertaken to
evaluate the efficacy of iron therapy in a group of children
with BHS.
Materials & Methods:
This study is a clinical trial conducted on infants with a
history of breath holding spells, referring to the Bandar
Abbas Pediatric Neurology Clinic between April 1999
and April 2001. A pediatric neurologist diagnosed the
subjects as having BHS. In this clinical trial, the frequency
of spells before and after iron supplementation were
investigated, recorded and compared.
 Sex, age, age of onset of BHS, number of spells, family
history, past medical history, developmental status, history
of use of oral iron supplements and history of convulsions
was documented; all related information was recorded
in a questionnaire. Infants were categorized as cyanotic,
pallid or mixed type according to criteria (2). Laboratory
tests including (complete blood count, serum iron, total
iron binding capacity, MCV, MCH, ferritin and transferrin
saturation index (SI=serum iron/TIBC×100) were done
for each patient; on the basis of these tests, patients were
classified into three groups: 1) Normal subjects 2) Iron
deficiency without anemia (serum ferritin <10 ng/ml,
SI<12% for children under 4 years, <14% for children
under 6 years, serum iron <50mg/dl and TIBC>400mg/dl)
and 3) Iron deficiency anemia with Hb<10.
 All affected patients, regardless of iron status, were
treated with oral iron (6 mg/Kg daily for 3 months). After
three months of therapy, parents were questioned on
frequency of spells. According to the data obtained on
reduction in attacks, patients were classified into 4 groups:
1- Complete response (no spell) 2- Good response (>
50% reduction in spells) 3- Poor response (10-50%
reduction in spells) and 4- No response (6).
Data was analyzed using the SPSS software version 10
Results:
35 patients, [19 males (54.3%) and 16 females (45.7%)]
were treated with oral iron supplements. Table- 1 shows
age of onset of spells. Most of the patients (66%) were
aged between 6 to 24 months. In 5 patients there were
positive family histories of BHS; 31 patients (88.5%)
had the cyanotic type, 3 (8.5%) the pallid type and 1
patient (3%) had the mixed type.
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14 patients (40%) had iron deficiency anemia, 20 patients
(57.1%) had reduced iron stores and just one patient had
a normal iron profile. Response to treatment was assessed
after 3 months of treatment in 4 groups of patients and
results are shown in tables 1 and 2 and in Fig 1.
Discussion
Breath holding spells (BHS), a well-known entity in
infants and children has an average prevalence is about
4-5 %( 6). BHS is more common in males, the male to
female ratio being around 1.3:1, as reported by many
studies (7, 8); in our study the ratio was found to be about
1.2:1. In a study conducted in the Connecticut children’s
hospital over a 9-year duration, there was no significant
difference between genders (9); in this study of 95 children
with BHS, median age of onset of spells was between 6-
12 months with 15% presenting below the age of 6
months (9). Lombroso and Lerman found breath-holding
spells in 4.6% of infants, with the majority of spells
(76%) beginning in infants between 6 -18 months of age
(6). In the Bridge study conducted on 83 patients, age of
onset of spells in 80% was under 18 months (7). In
another study, 87% of patients manifested symptoms
before 18 months and 100% before 22 months of life
(10). In our study, age of onset of spells was under 18
months in 77.2% of patients (Table-1).
Family pedigree analysis of children with BHS suggests
an autosomal dominant pattern of inheritance with reduced
penetration (10). In a study undertaken in the Hartford
center in USA, family pedigrees of 57 probands were
examined, of which 27% of proband parents and 21%
of proband siblings had severe current or prior BHS (10).
In another study positive family history of BHS was
identified in 34% of subjects (9). In our study, positive
family history was found in 14.3% of cases. Researchers
believe that in areas with increased prevalence of iron
Table1: Relative frequency of patients affected by breath holding spells based on age of onset of attacks:
Table2: Effects of iron therapy on patients with BHS based on the severity of iron deficiency:
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deficiency, these spells are observed regardless of impact
of family history(2,6).
In our study, 88.5% of spells were of the cyanotic, 8.5%
of the pallid and 3% of the mixed type. In one large study
of patients with BHS, 62% episodes were cyanotic,19%
were pallid and 19% were of the mixed type (6). This
discrepancy may have been be caused by misinterpretation
of different investigators in distinguishing between the
pallid and mixed types.
Various investigations have been conducted determine
the association between iron deficiency and BHS, resulting
in several hypotheses. Holowach and Thurston were the
first to identify increased frequency of BHS among iron
deficient infants (4). Researchers have observed that
infants with severe BHS had lower hemoglobin levels,
reduced serum iron and increased total iron binding
capacity vs. controls (4, 5). Breath-holding episodes have
been reported in up to 27% of children with iron deficiency
anemia (3). Iron plays an important role in regulation of
neurologic functions; it may reduce the level of
monoamine oxidase in the brain by increasing the urinary
norepinephrine excretion, and since this enzyme regulates
many brain activities, its deficiency may have an adverse
effect brain functions (2, 11). It also appears that
supplementation of iron has an effect on improving the
dysregulation of autonomic nervous system reflexes (12).
Several studies conducted investigating the effects of
iron in treatment of BHS have all indicated that a strong
association exists between BHS and iron deficiency (11-
14). In our study, majority of children (68.6%) showed
a complete response according to the standard definition
and 25.7% had a good response to iron therapy;(6) these
results were in agreement with published data(complete
response + good response=94.3%). In a prospective study,
91 children (56 boys, 35 girls) aged between 6 and 40
months were followed for a median of 45 months. All
patients were evaluated initially and during follow up
for hematological indices. 63 patients were found to have
iron deficiency anemia and were treated with iron
(6mg/kg/day) for 3 months, after which there was a
significant difference in frequency of cyanotic spells
(84.1% vs. 21.4%) between children treated with iron
and those who had not.  In another study in Jordan, sixty-
seven children with BHS were evaluated for effect of
iron therapy on BHS; children divided into two groups,
received iron or placebo. Those receiving iron showed
significant reduction in the frequency of spells (88%),
as compared with the frequency of spells (6%) in the
placebo group (14).
A major difference between our trial and other studies
may be the socioeconomic and cultural problems in
Hormozgan province. Severe malnutrition, large families
and lack of iron supplements may explain the apparently
high frequency of iron deficiency in the BHS patients
enrolled in this study. The prevalence of iron deficiency
in Hormozgan province should however be determined
in an epidemiologic study. It is noteworthy that patients
with mild BHS, not basically iron deficient, had not been
referred to our clinic, the only pediatric neurology clinic
in the region. This prevented us from evaluating the effect
of iron on nonanemic subjects with BHS.
Conclusion:
In conclusion, we recommend iron supplements for iron-
deficient patients with BHS.. Further studies with greater
sample size are recommended to evaluate the impact of
iron on reducing frequencies of spells and maybe even
the effect of iron in subjects with normal iron status.
Considering the benign nature of this disorder and
availability of simple treatments such as oral iron
supplements, physicians need to be cautioned against
prescribing anticonvulsants for the treatment of breath
holding spells.
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